Jeffrey E. Jacob insider trades: Panbela Therapeutics (PBLA) SEC Form 4 filings

About Jeffrey E. Jacob's insider trades

Jeffrey E. Jacob is a director at Panbela Therapeutics (PBLA). Jeffrey has not reported an open-market purchase or sale.

Their filings also include gifts (1 filing), grants and awards (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PBLA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.